Russell Alan J

Edgewise Therapeutics, Inc. ยท Chief Scientific Officer

Russell Alan J is listed in public filings as director, officer: Chief Scientific Officer. This Russell Alan J insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Edgewise Therapeutics, Inc. (EWTX). Investors use Russell Alan J's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Edgewise Therapeutics, Inc.EWTX$494k23.4k sharesSellNov 12, 2025$2.1M100k shares$21.12--
Edgewise Therapeutics, Inc.EWTX$22k123.4k sharesGrant / ExerciseNov 12, 2025$18.0K100k shares$0.18--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Edgewise Therapeutics, Inc.EWTX$342k23.4k sharesSellAug 26, 2025$1.5M100k shares$14.60--
Edgewise Therapeutics, Inc.EWTX$22k123.4k sharesGrant / ExerciseAug 26, 2025$18.0K100k shares$0.18--
Edgewise Therapeutics, Inc.EWTX$2.3M168.8k sharesGrant / ExerciseAug 12, 2025$2.3M168.8k shares$13.39--
Edgewise Therapeutics, Inc.EWTX--17.3k sharesGrant / ExerciseAug 12, 2025Disclosure amount unavailable5.8k shares----
Edgewise Therapeutics, Inc.EWTX--28.1k sharesGrant / ExerciseAug 12, 2025Disclosure amount unavailable28.1k shares----
Edgewise Therapeutics, Inc.EWTX$313k23.4k sharesSellAug 12, 2025$25.5K1.9k shares$13.39--
Edgewise Therapeutics, Inc.EWTX$305k18.5k sharesSellMay 2, 2025$25.5K1.6k shares$16.45--
Edgewise Therapeutics, Inc.EWTX--5.2k sharesGrant / ExerciseMay 1, 2025Disclosure amount unavailable5.2k shares----
Edgewise Therapeutics, Inc.EWTX$2.7k15.1k sharesGrant / ExerciseMar 7, 2025$36200 shares$0.18--
Edgewise Therapeutics, Inc.EWTX$446k14.9k sharesSellMar 7, 2025$6.0K200 shares$30.02--
Edgewise Therapeutics, Inc.EWTX$2.9k16.1k sharesGrant / ExerciseFeb 6, 2025$2161.2k shares$0.18--
Edgewise Therapeutics, Inc.EWTX$448k14.9k sharesSellFeb 6, 2025$36.2K1.2k shares$30.13--
Edgewise Therapeutics, Inc.EWTX$446k14.9k sharesSellFeb 5, 2025$240.6K8k shares$30.02--
Edgewise Therapeutics, Inc.EWTX$4.1k22.9k sharesGrant / ExerciseFeb 5, 2025$1.4K8k shares$0.18--
Edgewise Therapeutics, Inc.EWTX$407k14.9k sharesSellDec 30, 2024$2.7M100k shares$27.37--
Edgewise Therapeutics, Inc.EWTX$21k114.9k sharesGrant / ExerciseDec 30, 2024$18.0K100k shares$0.18--
Edgewise Therapeutics, Inc.EWTX$382k13.5k sharesSellSep 20, 2024$2.1M74.2k shares$28.25--
Edgewise Therapeutics, Inc.EWTX$375k12.7k sharesSellSep 20, 2024$24.0K815 shares$29.51--
Edgewise Therapeutics, Inc.EWTX$16k87.7k sharesGrant / ExerciseSep 20, 2024$13.5K75k shares$0.18--
Edgewise Therapeutics, Inc.EWTX$2.4M138.8k sharesGrant / ExerciseAug 12, 2024$2.4M138.8k shares$17.05--
Edgewise Therapeutics, Inc.EWTX--23.1k sharesGrant / ExerciseAug 12, 2024Disclosure amount unavailable23.1k shares----